Volume 11, Number 9—September 2005
Research
Molecular Epidemiology of SARS-associated Coronavirus, Beijing
Wei Liu*, Fang Tang*, Arnaud Fontanet†, Lin Zhan*, Tian-Bao Wang‡, Pan-He Zhang*, Yi-He Luan‡, Chao-Yang Cao‡, Qiu-Min Zhao*, Xiao-Ming Wu*, Zhong-Tao Xin§, Shu-Qing Zuo*, Laurence Baril†, Astrid Vabret¶, Yi-Ming Shao#, Hong Yang*, and Wu-Chun Cao*
Table 2
Epidemiologic and phylogenetic data on 29 severe acute respiratory syndrome patients, Beijing, 2003*
| Patient no. (sex, age [y]) | Onset date† | Sampling date,† clinical sample | 5-loci genotype | Other variant loci |
|---|---|---|---|---|
| 1‡ (M, 25) | 3/10 | 4/28, Sp | GGCTC | 22589 |
| 2ठ(F, 48) | 3/21 | 4/28, Sp | GGCTC | 22589, 27749 |
| 3 (M, 19) | 3/31 | 4/28, Sp; 5/5, Sp | GGCTC | 22589 |
| 4‡ (F, 34) | 3/31 | 5/5, St; 4/28, Sp | TGTTT | 17620, 22589 |
| 5ठ(M, 21) | 3/31 | 4/28, Sp; 5/5, Sp | TGTTT | 22589 |
| 6‡ (F, 34) | 4/2 | 4/28, Sp | TGTTT | 22077 |
| 7 (F, 27) | 4/2 | 4/28, Sp | GGCTC | 22589 |
| 8‡ (M, 31) | 4/3 | 4/28, Sp | TGTTT | 22077, 22589, 27749 |
| 9‡ (M, 20) | 4/5 | 5/5, Sp; 4/28, Sp | TGTTT | 17620, 22077, 22589 |
| 10 (F, 23) | 4/8 | 5/22, St; 5/15, Sp | GGCTC | 22589 |
| 11§ (M, 47) | 4/8 | 5/5-Sp; 5/5, St | GGCTC | 22589 |
| 12 (M, 73) | 4/9 | 4/28, Sp; 4/28, St | TGTTT | 22589, 27749 |
| 13 (M, 54) | 4/9 | 4/28, Sp; 4/28, St | GGCTC | 22589, 27749 |
| 14‡ (F, 21) | 4/11 | 4/28, Sp; 4/28, St; 5/5, Sp | TGTTT | |
| 15§ (M, 61) | 4/12 | 5/22, Sp | GATTC | 22589 |
| 16‡ (F, 25) | 4/15 | 5/5, Sp | TGTTT | 17620, 22589, 27749 |
| 17 (M, 25) | 4/17 | 5/5, Sp | TGTTT | 22077, 22589, 27749 |
| 18 (F, 20) | 4/18 | 4/28, Sp; 4/28, St | TGTTT | 22589, 27749 |
| 19‡ (F, 25) | 4/20 | 5/5, Sp; 5/5, St | TGTTT | 22077, 22589, |
| 20 (F, 34) | 4/21 | 4/28, Sp; 5/5, Sp | TGTTT | 22077 |
| 21 (M, 33) | 4/23 | 5/5, Sp; 5/5 St; 4/28-Sp | TGTTT | 17620, 22589 |
| 22 (M, 28) | 4/24 | 5/5, Sp | TGTTT | 22589, 27749 |
| 23 (M, 61) | 5/1 | 5/15, Sp | GATTC | 22589 |
| 24‡ (F, 31) | 5/1 | 5/5, Sp | TGTTT | 22077, 2589, 7749 |
| 25 (M, 25) | 5/2 | 5/7, Sp | TGTTT | 22077 |
| 26‡ (M, 25) | 5/4 | 5/22, Sp | TGTTT | 22077 |
| 27 (M, 19) | 5/6 | 5/22, Sp | TGTTT | 22589, 27749 |
| 28 (F, 28) | 5/7 | 5/22, Sp | TGTTT | 17620, 22589, 27749 |
| 29 (M, 22) | 5/12 | 4/28, Sp; 5/5, Sp | TGTTT | 22589, 27749 |
*F, female; M, male; Sp, sputum; St, stool.
†All dates are in 2003.
‡Patients were from the same cluster.
§Patients with adverse clinical outcome.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.